Dunne F P, Feely M P, Ferriss J B, Keohane C, Murphy D, Perry I
Department of Medicine, Regional Hospital, Cork, Ireland.
Q J Med. 1990 Apr;75(276):345-54.
Hypersecretion of TSH by a pituitary adenoma is thought to be a rare form of hyperthyroidism. We describe three such patients, each of whom presented with clinical hyperthyroidism and a diffuse goitre, without eye signs or dermatopathy. Two were receiving long-term phenothiazine, one of these was also acromegalic. Plasma thyroxine, free T4 and tri-iodothyronine were repeatedly raised in each; plasma TSH was grossly elevated in one and inappropriately normal in the other two. Plasma TSH did not rise in response to thyrotrophin-releasing hormone or metoclopramide and was not suppressed by L-dopa in any patient. Anti-thyrotrophin receptor antibodies were undetectable. Skull radiographs showed erosion and expansion of the pituitary fossa and CT scans confirmed a pituitary mass in each patient. A pituitary adenoma was removed by transphenoidal surgery in two patients and a TSH-secreting adenoma was confirmed by immunocytochemical staining and electron microscopy. Both patients were clinically euthyroid post-operatively but still had evidence of TSH excess. Pituitary surgery was technically unsuccessful in the third patient. Although two patients had hyperthyroidism of long duration, all three were diagnosed within one year of the introduction of a sensitive TSH assay to our laboratory. A TSH-secreting pituitary adenoma may be a more common cause of hyperthyroidism than has been believed.
垂体腺瘤导致促甲状腺激素分泌过多被认为是一种罕见的甲状腺功能亢进形式。我们描述了三名这样的患者,他们均表现为临床甲状腺功能亢进和弥漫性甲状腺肿,无眼部体征或皮肤病。两名患者长期服用吩噻嗪,其中一名还患有肢端肥大症。每位患者的血浆甲状腺素、游离T4和三碘甲状腺原氨酸均反复升高;一名患者的血浆促甲状腺激素显著升高,另外两名患者的血浆促甲状腺激素则异常正常。任何患者的血浆促甲状腺激素对促甲状腺激素释放激素或甲氧氯普胺均无反应,且不受左旋多巴抑制。未检测到抗促甲状腺激素受体抗体。颅骨X线片显示垂体窝侵蚀和扩大,CT扫描证实每位患者均有垂体肿块。两名患者通过经蝶窦手术切除了垂体腺瘤,免疫细胞化学染色和电子显微镜检查证实为促甲状腺激素分泌腺瘤。两名患者术后临床甲状腺功能正常,但仍有促甲状腺激素过量的证据。第三名患者的垂体手术在技术上未成功。尽管两名患者患有长期甲状腺功能亢进,但在我们实验室引入敏感促甲状腺激素检测方法后的一年内,三名患者均被确诊。分泌促甲状腺激素的垂体腺瘤可能是比人们认为的更常见的甲状腺功能亢进原因。